Reliv Unveils New LunaRich X Encapsulation Line

View Reliv International Profile

4/16/2015

CHESTERFIELD, MO, Apr 14, 2015 -- Reliv International, Inc. RELV, a maker of nutritional supplements that promote optimal health, today announced that the company has installed a new state-of-the-art encapsulation line at Reliv headquarters to manufacture LunaRich X(TM), a concentrated lunasin supplement. Reliv made the announcement to its distributors this week via a one-minute video.

LunaRich X is the most pure, concentrated form of bioactive lunasin ever produced. Since its launch in January 2013, LunaRich X was named Consumer Product of the Year by the American Business Awards, was shown to aid in promoting metabolic health in a University of Missouri study and has sold more than 12 million capsules worldwide.

"The new line will help meet increasing demand and further elevate Reliv's renowned quality control," said Brett Hastings, Reliv's chief operating officer. "We can now manufacture more than 48,000 capsules per hour to support the growing businesses of Reliv distributors around the world. The line will also keep costs low and pave the way for future encapsulated product offerings."

LunaRich X marks the culmination of an extensive research and development process that began with the discovery of the lunasin peptide by research scientist Dr. Alfredo Galvez at UC Berkley in 1996. Lunasin is a naturally occurring soy peptide and the first nutritional compound identified to work at the epigenetic level to promote optimal health. It is now one of the most heavily researched and scientifically supported nutritional compounds available today, with more than 80 published papers from more than 30 research institutions.